New An in-depth review discussing two posters presented at ESC 2019
With
Søren Paaske Johnsen
With
Daniele Pastori
Approx. time required 60 mins
Watch nowNew Bleeding and new cancer diagnosis in patients with atherosclerosis
With
John Eikelboom
Approx. time required 30 mins
Watch nowNew Full Study Report of Andexanet Alfa for Bleeding Associated with Factor Xa Inhibitors
With
Stuart Connolly
Approx. time required 30 mins
Watch nowBetrixaban versus enoxaparin for VTE in critically ill patients: an APEX substudy
With
Russell Hull
Approx. time required 30 mins
Watch nowTwo of the questions asked most often are which NOAC to take for which patient, and what's the relevance and clinical role of NOAC antidotes. Thus, there is still much more room and necessity for high-level and independent medical education in this field.
Professor Dr Harald Darius, NOAC faculty member